Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 3/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.62 |
| ▸ | MEN1 | O00255 | 5/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.59 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.57 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.57 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.57 |
| ▸ | PKM | P14618 | 3/20 | 0.57 |
| ▸ | TP53 | P04637 | 1/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.53 |
| ▸ | GFER | P55789 | 1/20 | 0.52 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.52 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14601741 | 0.81 | ALDH1A1 (0.56) | GAAALDH1A1MEN1KMT2AHDAC1 | |
| SCHEMBL808364 | 0.77 | ALDH1A1 (1.00) | GAAALDH1A1MEN1KMT2AHDAC1 | |
| SCHEMBL17696037 | 0.75 | MEN1 (0.71) | GAAALDH1A1MEN1KMT2AHDAC1 | |
| SCHEMBL30553888 | 0.75 | MAPK1 (0.68) | GAAALDH1A1MEN1KMT2AHTT | |
| SCHEMBL2459763 | 0.75 | MAPK1 (0.68) | GAAALDH1A1MEN1KMT2AHTT | |
| SCHEMBL10192086 | 0.75 | MEN1 (0.75) | GAAALDH1A1MEN1KMT2AHDAC1 | |
| SCHEMBL9997278 | 0.74 | PFKFB3 (0.67) | GAAALDH1A1MEN1KMT2AHDAC1 | |
| SCHEMBL808360 | 0.74 | ALDH1A1 (0.67) | GAAALDH1A1MEN1KMT2AHDAC1 | |
| SCHEMBL2702246 | 0.74 | ALDH1A1 (0.76) | GAAALDH1A1MEN1KMT2AHDAC1 | |
| SCHEMBL30708093 | 0.74 | ALDH1A1 (0.76) | GAAALDH1A1MEN1KMT2AHDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070021509-A1 | Phosphate transport inhibitors | JOZEFIAK THOMAS H | 2007-01-25 | — | — | US | disclosed |
| US-20070021509-A1 | Phosphate transport inhibitors | JOZEFIAK THOMAS H | 2007-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070021509-A1 | Phosphate transport inhibitors | SLC34A2, SLC34A1, SLC20A1 | GAA 536/4885ALDH1A1 2163/4885MEN1 2248/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.